News & Events

Related Pages

Webinar Watch

The amendments to regulation E-1 of the BWM Convention adopted by MECP 74 require biological efficacy testing when commissioning a BWTS on board a vessel. This amendment will come into effect on 1 June 2022. The test is conducted onboard, and commissioning testing is successful if the indicative analysis indicates that the discharge samples do not exceed the D-2 standard for the size classes analysed and the self-monitoring equipment indicates correct operation. But what happens if the commissioning test is unsuccessful? In this webinar, we explore the many issues that are surfacing around commissioning testing.

• Verification protocol of Compliance Monitoring Devices (CMD): what is and isn’t there
• Is there a CMD that meets all requirements?
• If a commissioning test fails, what happens next?
• Will there be enough commissioning testers?
• How many reports are in the EBP database?
• Should the EBP be extended?

DOWNLOAD THE PPT